U
NantHealth, Inc.
NHIQ
$0.0001
$0.000.00%
E
Sell
12/20/2024Downgrade
NantHealth, Inc. (NHIQ) was downgraded to E+ from D- on 12/20/2024 due to a decline in the volatility index.
NantHealth, Inc. (NHIQ) was downgraded to E+ from D- on 12/20/2024 due to a decline in the volatility index.
D
Sell
12/2/2024Upgraded
NantHealth, Inc. (NHIQ) was upgraded to D- from E+ on 12/2/2024 due to an increase in the volatility index.
NantHealth, Inc. (NHIQ) was upgraded to D- from E+ on 12/2/2024 due to an increase in the volatility index.
E
Sell
6/18/2024Downgrade
NantHealth, Inc. (NHIQ) was downgraded to E+ from D- on 6/18/2024 due to a decline in the volatility index.
NantHealth, Inc. (NHIQ) was downgraded to E+ from D- on 6/18/2024 due to a decline in the volatility index.
D
Sell
6/3/2024Upgraded
NantHealth, Inc. (NHIQ) was upgraded to D- from E+ on 6/3/2024 due to an increase in the volatility index and total return index.
NantHealth, Inc. (NHIQ) was upgraded to D- from E+ on 6/3/2024 due to an increase in the volatility index and total return index.
E
Sell
5/17/2024Downgrade
NantHealth, Inc. (NHIQ) was downgraded to E+ from D- on 5/17/2024 due to a decline in the volatility index.
NantHealth, Inc. (NHIQ) was downgraded to E+ from D- on 5/17/2024 due to a decline in the volatility index.
D
Sell
5/2/2024Upgraded
NantHealth, Inc. (NHIQ) was upgraded to D- from E+ on 5/2/2024 due to a noticeable increase in the volatility index and total return index.
NantHealth, Inc. (NHIQ) was upgraded to D- from E+ on 5/2/2024 due to a noticeable increase in the volatility index and total return index.
E
Sell
4/11/2024Upgraded
NantHealth, Inc. (NHIQ) was upgraded to E+ from E on 4/11/2024 due to an increase in the volatility index and total return index.
NantHealth, Inc. (NHIQ) was upgraded to E+ from E on 4/11/2024 due to an increase in the volatility index and total return index.
E
Sell
3/20/2024Downgrade
NantHealth, Inc. (NHIQ) was downgraded to E from E+ on 3/20/2024 due to a decline in the volatility index.
NantHealth, Inc. (NHIQ) was downgraded to E from E+ on 3/20/2024 due to a decline in the volatility index.
E
Sell
3/4/2024Upgraded
NantHealth, Inc. (NHIQ) was upgraded to E+ from E on 3/4/2024 due to an increase in the volatility index.
NantHealth, Inc. (NHIQ) was upgraded to E+ from E on 3/4/2024 due to an increase in the volatility index.
E
Sell
2/15/2024Downgrade
NantHealth, Inc. (NHIQ) was downgraded to E from E+ on 2/15/2024 due to a decline in the volatility index, growth index and total return index.
NantHealth, Inc. (NHIQ) was downgraded to E from E+ on 2/15/2024 due to a decline in the volatility index, growth index and total return index.
E
Sell
1/31/2024Upgraded
NantHealth, Inc. (NHIQ) was upgraded to E+ from E on 1/31/2024 due to an increase in the volatility index.
NantHealth, Inc. (NHIQ) was upgraded to E+ from E on 1/31/2024 due to an increase in the volatility index.
E
Sell
1/16/2024Downgrade
NantHealth, Inc. (NHIQ) was downgraded to E from E+ on 1/16/2024 due to a decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.21 to 0.06, and debt to equity increased from -1.12 to -1.1.
NantHealth, Inc. (NHIQ) was downgraded to E from E+ on 1/16/2024 due to a decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.21 to 0.06, and debt to equity increased from -1.12 to -1.1.
E
Sell
3/14/2023Downgrade
NantHealth, Inc. (NH) was downgraded to E+ from D- on 3/14/2023 due to a decline in the growth index.
NantHealth, Inc. (NH) was downgraded to E+ from D- on 3/14/2023 due to a decline in the growth index.
D
Sell
2/23/2023Upgraded
NantHealth, Inc. (NHIQ) was upgraded to D- from E+ on 02/23/2023.
NantHealth, Inc. (NHIQ) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
NantHealth, Inc. (NH) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and total return index.
NantHealth, Inc. (NH) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and total return index.
D
Sell
11/7/2022Downgrade
NantHealth, Inc. (NH) was downgraded to D- from D on 11/7/2022 due to a noticeable decline in the growth index, solvency index and volatility index. The quick ratio declined from 0.48 to 0.19, EBIT declined 20.88% from -$11.71M to -$14.16M, and earnings per share declined from -$0.1083 to -$0.12.
NantHealth, Inc. (NH) was downgraded to D- from D on 11/7/2022 due to a noticeable decline in the growth index, solvency index and volatility index. The quick ratio declined from 0.48 to 0.19, EBIT declined 20.88% from -$11.71M to -$14.16M, and earnings per share declined from -$0.1083 to -$0.12.
D
Sell
5/31/2022Upgraded
NantHealth, Inc. (NH) was upgraded to D from D- on 5/31/2022 due to an increase in the valuation index.
NantHealth, Inc. (NH) was upgraded to D from D- on 5/31/2022 due to an increase in the valuation index.
D
Sell
5/13/2022Downgrade
NantHealth, Inc. (NH) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index and valuation index.
NantHealth, Inc. (NH) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index and valuation index.
D
Sell
5/5/2022Upgraded
NantHealth, Inc. (NHIQ) was upgraded to D from D- on 05/05/2022.
NantHealth, Inc. (NHIQ) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
NantHealth, Inc. (NH) was downgraded to D- from D on 4/20/2022 due to a major decline in the total return index and growth index. Earnings per share declined from -$0.0941 to -$0.1447, and EBIT declined 7.14% from -$11.07M to -$11.86M.
NantHealth, Inc. (NH) was downgraded to D- from D on 4/20/2022 due to a major decline in the total return index and growth index. Earnings per share declined from -$0.0941 to -$0.1447, and EBIT declined 7.14% from -$11.07M to -$11.86M.
D
Sell
11/23/2021Upgraded
NantHealth, Inc. (NH) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and valuation index.
NantHealth, Inc. (NH) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and valuation index.
D
Sell
11/8/2021Downgrade
NantHealth, Inc. (NH) was downgraded to D- from D on 11/8/2021 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 1.94 to 1.49, and debt to equity increased from -1.91 to -1.79.
NantHealth, Inc. (NH) was downgraded to D- from D on 11/8/2021 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 1.94 to 1.49, and debt to equity increased from -1.91 to -1.79.
D
Sell
9/14/2020Downgrade
NantHealth, Inc. (NH) was downgraded to D from D+ on 9/14/2020 due to a noticeable decline in the total return index and volatility index.
NantHealth, Inc. (NH) was downgraded to D from D+ on 9/14/2020 due to a noticeable decline in the total return index and volatility index.
D
Sell
8/12/2020Upgraded
NantHealth, Inc. (NH) was upgraded to D+ from D on 8/12/2020 due to a major increase in the total return index, solvency index and volatility index. The quick ratio increased from 1.81 to 1.81.
NantHealth, Inc. (NH) was upgraded to D+ from D on 8/12/2020 due to a major increase in the total return index, solvency index and volatility index. The quick ratio increased from 1.81 to 1.81.
D
Sell
5/1/2020Upgraded
NantHealth, Inc. (NH) was upgraded to D from D- on 5/1/2020 due to a substantial increase in the total return index, growth index and volatility index. EBIT increased 32.24% from -$6.77M to -$4.59M, earnings per share increased from -$0.15 to -$0.1106, and total revenue increased 8.2% from $22.36M to $24.19M.
NantHealth, Inc. (NH) was upgraded to D from D- on 5/1/2020 due to a substantial increase in the total return index, growth index and volatility index. EBIT increased 32.24% from -$6.77M to -$4.59M, earnings per share increased from -$0.15 to -$0.1106, and total revenue increased 8.2% from $22.36M to $24.19M.
D
Sell
10/4/2019Upgraded
NantHealth, Inc. (NH) was upgraded to D- from E+ on 10/4/2019 due to an increase in the volatility index and total return index.
NantHealth, Inc. (NH) was upgraded to D- from E+ on 10/4/2019 due to an increase in the volatility index and total return index.
E
Sell
9/10/2019Downgrade
NantHealth, Inc. (NH) was downgraded to E+ from D- on 9/10/2019 due to a decline in the solvency index, growth index and volatility index. Debt to equity increased from -12.44 to -6.72, and the quick ratio declined from 0.77 to 0.64.
NantHealth, Inc. (NH) was downgraded to E+ from D- on 9/10/2019 due to a decline in the solvency index, growth index and volatility index. Debt to equity increased from -12.44 to -6.72, and the quick ratio declined from 0.77 to 0.64.
D
Sell
5/15/2019Upgraded
NantHealth, Inc. (NH) was upgraded to D- from E+ on 5/15/2019 due to a significant increase in the solvency index, valuation index and growth index. Debt to equity declined from 70.81 to -13.2, earnings per share increased from -$0.4491 to -$0.1813, and total revenue increased 3.8% from $22.86M to $23.73M.
NantHealth, Inc. (NH) was upgraded to D- from E+ on 5/15/2019 due to a significant increase in the solvency index, valuation index and growth index. Debt to equity declined from 70.81 to -13.2, earnings per share increased from -$0.4491 to -$0.1813, and total revenue increased 3.8% from $22.86M to $23.73M.
E
Sell
4/3/2019Downgrade
NantHealth, Inc. (NH) was downgraded to E+ from D- on 4/3/2019 due to a significant decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 3.89 to 70.81, total capital declined 18.79% from $250.36M to $203.31M, and the quick ratio declined from 1.09 to 0.95.
NantHealth, Inc. (NH) was downgraded to E+ from D- on 4/3/2019 due to a significant decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 3.89 to 70.81, total capital declined 18.79% from $250.36M to $203.31M, and the quick ratio declined from 1.09 to 0.95.
D
Sell
3/29/2019Upgraded
NantHealth, Inc. (NH) was upgraded to D- from E+ on 3/29/2019 due to an increase in the volatility index.
NantHealth, Inc. (NH) was upgraded to D- from E+ on 3/29/2019 due to an increase in the volatility index.
E
Sell
11/26/2018Downgrade
NantHealth, Inc. (NH) was downgraded to E+ from D- on 11/26/2018 due to a noticeable decline in the growth index, solvency index and efficiency index. Net income declined 316.57% from -$23.4M to -$97.46M, earnings per share declined from -$0.2146 to -$0.8903, and debt to equity increased from 1.34 to 3.89.
NantHealth, Inc. (NH) was downgraded to E+ from D- on 11/26/2018 due to a noticeable decline in the growth index, solvency index and efficiency index. Net income declined 316.57% from -$23.4M to -$97.46M, earnings per share declined from -$0.2146 to -$0.8903, and debt to equity increased from 1.34 to 3.89.
D
Sell
8/27/2018Downgrade
NantHealth, Inc. (NH) was downgraded to D- from D on 8/27/2018 due to a decline in the growth index, volatility index and solvency index. The quick ratio declined from 1.69 to 1.31, debt to equity increased from 1.15 to 1.34, and earnings per share declined from -$0.2042 to -$0.2146.
NantHealth, Inc. (NH) was downgraded to D- from D on 8/27/2018 due to a decline in the growth index, volatility index and solvency index. The quick ratio declined from 1.69 to 1.31, debt to equity increased from 1.15 to 1.34, and earnings per share declined from -$0.2042 to -$0.2146.
D
Sell
3/16/2018Upgraded
NantHealth, Inc. (NH) was upgraded to D from D- on 3/16/2018 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.3672 to -$0.2007, and total revenue increased 2.47% from $21.76M to $22.3M.
NantHealth, Inc. (NH) was upgraded to D from D- on 3/16/2018 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.3672 to -$0.2007, and total revenue increased 2.47% from $21.76M to $22.3M.
D
Sell
1/20/2017Downgrade
NantHealth, Inc. (NH) was downgraded to D- from D on 1/20/2017 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 2.04 to 1.65, and debt to equity increased from 0.23 to 0.25.
NantHealth, Inc. (NH) was downgraded to D- from D on 1/20/2017 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 2.04 to 1.65, and debt to equity increased from 0.23 to 0.25.
D
Sell
9/2/2016Upgraded
NantHealth, Inc. (NH) was upgraded to D from D- on 9/2/2016 due to an increase in the total return index and volatility index.
NantHealth, Inc. (NH) was upgraded to D from D- on 9/2/2016 due to an increase in the total return index and volatility index.
D
Sell
8/25/2016None
NantHealth, Inc. (NHIQ) was downgraded to D- from U on 08/25/2016.
NantHealth, Inc. (NHIQ) was downgraded to D- from U on 08/25/2016.
OTC PK
03/12/2025 3:10PM Eastern
Quotes delayed
